News

Filter

226 to 235 of 97252 results

Array BioPharma to regain global rights to binimetinib from Novartis

04-12-2014

Shares of US biotech firm Array BioPharma leapt 22.8% to $4.80 in after-hours trading on Wednesday, after…

Array BioPharmabinimetinibBiotechnologyGlobalLicensingNovartisOncology

Added benefit of Lundbeck’s Selincro not proven, says IQWiG

04-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment…

GermanyLundbeckNeurologicalPharmaceuticalPricingRegulationSelincro

ABPI welcomes Chancellor’s decision to increase rate of R&D tax credits

04-12-2014

In his Autumn Statement yesterday, UK Chancellor of the Exchequer, George Osborne said he wants to help…

FinancialPharmaceuticalResearchUK

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

EMA committee concludes no evidence Fluad caused deaths

EMA committee concludes no evidence Fluad caused deaths

04-12-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

EuropeFluadNovartisPharmaceuticalRegulationVaccines

ADMA’s lead product meets primary endpoint in Phase III trial

04-12-2014

US-based biopharmaceutical company ADMA Biologics says that its lead product candidate RI-002 has demonstrated…

ADMA BiologicsImmunologicalsPharmaceuticalResearchRI-002USA

Age-related macular degeneration treatment market to reach $10 billion by 2023

Age-related macular degeneration treatment market to reach $10 billion by 2023

04-12-2014

The market for treatments of age-related macular degeneration across seven major countries will almost…

AvastinEuropeEyleaFovistaLucentisMarkets & MarketingOphthalmicsPharmaceuticalUSA

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

04-12-2014

Ahead of the anticipated decision date, the US Food and Drug Administration yesterday approved Blincyto…

AmgenBiotechnologyblinatumomabBlincytoOncologyRegulationUSA

226 to 235 of 97252 results

Back to top